Medical Properties Trust Inc MPW.N, MPW is expected to show a fall in quarterly revenue when it reports results on February 19 (estimated) for the period ending December 31 2024
The Birmingham Alabama-based company is expected to report a 35.4% decrease in revenue to $217.568 million from $336.62 million a year ago, according to the mean estimate from 8 analysts, based on LSEG data. (SAL represents Property/Total Revenue)
LSEG's mean analyst estimate for Medical Properties Trust Inc is for a loss of 6 cents per share.
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy," 7 "hold" and 4 "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Medical Properties Trust Inc is $4.50, below its last closing price of $4.95.
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Sep. 30 2024 | 0.19 | 0.20 | 0.16 | Missed | -21.1 |
Jun. 30 2024 | 0.21 | 0.22 | 0.23 | Beat | 5.1 |
Mar. 31 2024 | 0.25 | 0.27 | 0.24 | Missed | -11 |
Dec. 31 2023 | 0.28 | 0.30 | 0.36 | Beat | 21.4 |
Sep. 30 2023 | 0.35 | 0.36 | 0.38 | Beat | 7 |
Jun. 30 2023 | 0.37 | 0.37 | 0.48 | Beat | 28.8 |
Mar. 31 2023 | 0.38 | 0.37 | 0.37 | Met | -1.2 |
Dec. 31 2022 | 0.43 | 0.43 | 0.43 | Met | -0.3 |
This summary was machine generated February 17 at 13:33 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。